✨ Free AI Report
Prime Medicine, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Prime Medicine, Inc.
Research Preview

Prime Medicine, Inc.: Business Overview, Financials & Competitive Analysis

Prime Medicine is a biotechnology company engaged in creating and delivering gene editing therapies using its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology to develop o...

Analyst-debate audio for Prime Medicine, Inc.

AskCyborg analysts argue the bull and bear cases for Prime Medicine, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Prime Medicine, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
5/ 10Mixed

Cyborg Score thesis

Early-stage gene editing biotech with differentiated platform technology and diversified pipeline, but dependent on clinical data...

Read the full analyst-debate transcript →
Industry Biotechnology - Gene Editing & Gene Therapy
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest Prime Medicine, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Prime Medicine, Inc. Overview

Pro stress-test →

Prime Medicine is a biotechnology company engaged in creating and delivering gene editing therapies using its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology to develop one-time curative genetic therapies. The company leverages innovative genetic editing to address serious genetic diseases with potential to transform treatment paradigms.

Strategic Profile

Pro stress-test →

The company is advancing a set of high-value programs across its core areas of focus including hematology, immunology and oncology, liver, and lung. In November 2025, Prime appointed Matthew Hawryluk as Chief Business Officer to lead corporate and business development, corporate strategy, and alliance management to expand Prime Editing through strategic partnerships.

Competitive Landscape

Pro stress-test →

Prime Medicine competes in the gene editing space with other CRISPR and advanced gene editing platforms. Comparable companies in the biotech gene editing sector include Caribou Biosciences, Beam Therapeutics, Intellia Therapeutics, AbCellera Biologics, Sangamo Therapeutics, Sana Biotechnology, Editas Medicine, and Wave Life Sciences.

Industry Context

Prime Medicine, Inc. operates in Biotechnology - Gene Editing & Gene Therapy.

Key facts

Founded: 2019 · Headquarters: Cambridge, MA · Employees: 214 · Market cap: $0.67B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Prime Medicine, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Prime Medicine, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

CRISPR Gene EditingCRISPR-based in vivo gene editing therapies→Base EditingBase editing gene therapy platform→Programmable Cell TherapyCRISPR-based allogeneic CAR-T cell therapy→

Compare Prime Medicine, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Prime Medicine, Inc. operates in Biotechnology - Gene Editing & Gene Therapy. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology - Gene Editing & Gene Therapy research →
NEW · MCP server

Ask your AI assistant about Prime Medicine, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Prime Medicine, Inc. and its top competitor on Cyborg Score”
“What did Prime Medicine, Inc. do this quarter?”
“Is Prime Medicine, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Prime Medicine, Inc. do?+
Prime Medicine is a biotechnology company engaged in creating and delivering gene editing therapies using its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology to develop o...
What is Prime Medicine, Inc.'s Cyborg Score?+
Prime Medicine, Inc. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Prime Medicine, Inc.'s main competitors?+
Named competitors include CRISPR Gene Editing, Base Editing, Programmable Cell Therapy. The full competitive landscape is in the AskCyborg report.
How can I get the full Prime Medicine, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Prime Medicine, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Prime Medicine, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9National Bank of Pakistan9RENK Group AG9Lumentum Holdings Inc.9First Abu Dhabi Bank9The Travelers Companies, Inc.9BAE Systems plc9Arista Networks9KLA Corporation9Hermès International S.A.8Enerjisa Enerji A.Ş.8Emirates Central Cooling Systems Corporation8WALLIX Group8StealthGas Inc.8SofWave Medical Ltd.8Himalaya Shipping Ltd.8Bannerman Energy Ltd8Sembcorp Salalah Power & Water Company8MilDef Group